HLA-DQB1 rs455804: What Your Genotype Means
The rs455804 variant is a genetic marker located within the HLA-DQB1 gene region. It has been identified in research studies as being statistically associated with the risk of developing hepatocellular carcinoma in individuals who are chronic carriers of the hepatitis B virus.
What each genotype means
Lower hepatocellular carcinoma risk
Research indicates that this genotype is associated with a lower risk of developing hepatocellular carcinoma in individuals who are chronic hepatitis B virus carriers. This association has been observed in Han Chinese populations, where the variant is thought to influence glutamate signaling pathways. Please discuss your overall liver health and any necessary screening protocols with your clinician.
This genotype is common in East Asian populations.
Intermediate risk profile
This genotype represents a heterozygous state for this variant, which has been studied in the context of hepatocellular carcinoma risk among chronic hepatitis B virus carriers. Statistical evidence suggests that carrying this genotype may result in a risk profile between the homozygous states. As this is a complex trait, please consult with your healthcare provider regarding your specific health history and appropriate monitoring.
This genotype is common in East Asian populations.
Higher hepatocellular carcinoma risk
Studies in Han Chinese populations have identified this genotype as being associated with a higher susceptibility to hepatocellular carcinoma in the presence of chronic hepatitis B infection. The variant is located within the GRIK1 gene, suggesting a potential role for glutamate signaling in liver disease progression. You should discuss your liver health and screening needs with your physician, as this is a statistical association and not a diagnosis.
This genotype is common in East Asian populations.
Understanding the rs455804 Variant
The rs455804 variant is a single-nucleotide polymorphism (SNP) situated in the human leukocyte antigen (HLA) region of the genome. Specifically, this variant is often discussed in the context of the HLA-DQB1 gene, which plays a critical role in the immune system. The HLA region is highly complex and is responsible for encoding proteins that help the immune system distinguish between the body's own cells and foreign invaders like viruses. Because this region is so vital for immune surveillance, variations here can influence how effectively the body responds to persistent infections. Researchers study these SNPs to understand why some individuals clear viral infections like hepatitis B while others develop chronic conditions that may progress to liver disease or cancer. It is important to note that rs455804 is a marker of statistical association rather than a direct cause of disease, and its presence does not guarantee any specific health outcome.
The Role of HLA-DQB1
The HLA-DQB1 gene provides instructions for making a protein that is part of the HLA class II molecule. These molecules are expressed on the surface of antigen-presenting cells, where they display peptide fragments to T-cells, a type of white blood cell. This interaction is essential for initiating an adaptive immune response. In the context of chronic hepatitis B virus (HBV) infection, the ability of the immune system to recognize and eliminate infected cells is paramount. Variations in HLA-DQB1 can alter the structure of these molecules, potentially affecting how well they present viral peptides to the immune system. When the immune response is suboptimal, the virus may persist, leading to chronic inflammation. Over many years, this chronic inflammation can damage liver tissue, increasing the risk of cirrhosis and hepatocellular carcinoma. The study of HLA-DQB1 variants helps scientists map the genetic landscape of immune-mediated responses to viral pathogens.
Research and Evidence Strength
The association between rs455804 and hepatocellular carcinoma (HCC) in chronic HBV carriers is supported by moderate evidence from genome-wide association studies (GWAS). Research, particularly in East Asian populations, has highlighted this locus as a susceptibility factor. While these studies provide valuable insights into the genetic architecture of liver cancer risk, the evidence is considered moderate because the biological mechanisms linking this specific SNP to disease progression are still being investigated. Furthermore, genetic associations can vary significantly between different ethnic groups due to differences in linkage disequilibrium and environmental factors. It is crucial to understand that these findings are based on population-level statistics. They describe trends observed in large groups of people and cannot be used to predict an individual's personal risk. The complexity of liver disease, which involves a combination of viral, environmental, and multiple genetic factors, means that a single SNP provides only a very small piece of the overall health puzzle.
Interpreting Your Information
If you have information about your rs455804 genotype, it is important to view it through the lens of scientific research rather than clinical diagnosis. This variant is a tool for researchers to understand disease susceptibility, not a diagnostic test for cancer. You cannot use this information to determine your personal risk of developing liver disease. If you are a carrier of the hepatitis B virus, your primary focus should be on regular monitoring and management as recommended by your healthcare provider. Do not make any changes to your medical care or screening schedule based on genetic data without consulting a physician. Genetic testing for such variants is not currently used in routine clinical practice to guide treatment decisions for hepatitis B. Always discuss your health concerns, family history, and any questions about your risk factors with a qualified medical professional who can provide personalized guidance based on your complete clinical picture.
How common is this variant?
The rs455804 variant is commonly observed in East Asian populations, where it has been the subject of several genetic association studies regarding hepatitis B outcomes.
Frequently asked questions
Is rs455804 a test for liver cancer?
No, rs455804 is not a diagnostic test for liver cancer. It is a genetic marker used in research to study statistical associations between genetics and disease susceptibility in specific populations.
Does having a specific rs455804 genotype mean I will get sick?
No, having a specific genotype does not mean you will develop a disease. Genetic associations are based on population averages and do not predict individual health outcomes.
Should I get tested for this SNP if I have hepatitis B?
There is no clinical recommendation to test for this SNP if you have hepatitis B. Management of hepatitis B should be based on clinical guidelines and regular monitoring by your doctor.
Where can I find more information on HLA-DQB1?
You can find reliable information about the HLA-DQB1 gene and its role in the immune system through resources like MedlinePlus Genetics or the National Center for Biotechnology Information (NCBI).
Sources & further reading
Educational information only, last refreshed 11/8/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs455804?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in HLA-DQB1
This variant in the HLA-DQB1 region is associated with peanut allergy susceptibility, reflecting the broader role of HLA class II variation in food allergy risk.
This variant is associated with susceptibility to asthma, seasonal allergic rhinitis, and Kawasaki disease.
Genetic variant in the HLA-DQB1 region associated with various autoimmune and inflammatory conditions.
Tag SNP within the major histocompatibility complex class II locus displaying strong association with susceptibility to Type 1 diabetes.
HLA class II region polymorphism exhibiting ancestry-specific risk architecture for peanut allergy.
Class II HLA-DQB1 variant exhibiting robust genome-wide association with IgE-mediated peanut allergy and egg sensitization.